Denver Post: On front line in cancer fight - Colorado, with several drugs in research stages, is seen as a "significant" player.

In a nod to Colorado's booming biotech industry, Pharmaceutical Research and Manufacturers of America issued a report in Denver on Wednesday responding to President Barack Obama's call in February for "a cure for cancer in our time."

"Colorado is clearly becoming one of the significant players in terms of oncology drug development," said Timothy Rodell, chief executive of GlobeImmune, a Louisville company founded by three University of Colorado scientists. "There is lot happening here right now."

Link to the Denver Post article